XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://biotechstocks.com/researchers-found-immunotherapy-may-treat-hiv-aids/20%Monthly2017-03-31 19:51
https://biotechstocks.com/amgn-to-highlight-new-preclinical-data/20%Monthly2017-03-31 13:23
https://biotechstocks.com/crbp-anti-inflammatory-drug-shows-promising-early-results-for-cf/20%Monthly2017-03-31 13:20
https://biotechstocks.com/cur-form-8-k-8/20%Monthly2017-03-31 13:16
https://biotechstocks.com/new-treatment-for-bacterial-pneumonia-discovered-at-university-of-virginia/20%Monthly2017-03-30 19:31
https://biotechstocks.com/vbiv-appoints-avi-mazaltov-as-global-head-of-manufacturing/20%Monthly2017-03-30 13:31
https://biotechstocks.com/kite-present-two-plenary-presentations-from-the-zuma-1-pivotal-trial/20%Monthly2017-03-30 13:26
https://biotechstocks.com/halo-provides-update-on-swog-collaborative-group-clinical-study/20%Monthly2017-03-30 13:21
https://biotechstocks.com/is-cancer-simply-based-on-luck/20%Monthly2017-03-29 19:56
https://biotechstocks.com/lclp-announces-consolidation-and-change-in-officers/20%Monthly2017-03-29 13:38
https://biotechstocks.com/gwph-announces-epidiolex-receives-orphan-drug-designation/20%Monthly2017-03-29 13:03
https://biotechstocks.com/alexion-pharmaceuticals-inc-nasdaqalxn-names-ludwig-hantson-its-new-ceo-following-a-recent-internal-sales-probe/20%Monthly2017-03-29 04:32
https://biotechstocks.com/tesaro-inc-nasdaqtsros-potential-blockbuster-cancer-drug-gets-approved-by-fda/20%Monthly2017-03-29 04:47
https://biotechstocks.com/the-european-commission-approves-amgen-inc-nasdaqamgns-humira-biosimilar/20%Monthly2017-03-29 04:30
https://biotechstocks.com/gilead-sciences-inc-nasdaqgild-faces-a-tough-patent-dispute-on-the-hep-c-bestseller/20%Monthly2017-03-29 04:29
https://biotechstocks.com/cerner-corporation-nasdaqcern-supports-missouris-joining-the-drug-monitoring-program/20%Monthly2017-03-29 04:27
https://biotechstocks.com/illinois-man-cured-of-rare-blood-disorder/20%Monthly2017-03-28 20:04
https://biotechstocks.com/aldr-to-present-at-the-16th-annual-needham-healthcare-conference/20%Monthly2017-03-28 13:10
https://biotechstocks.com/biib-to-present-data-at-the-13th-international-conference-on-alzheimers/20%Monthly2017-03-28 12:57
https://biotechstocks.com/ultragenyx-pharmaceutical-inc-nasdaqrare-fails-in-a-mid-stage-sources-say/20%Monthly2017-03-28 10:46
https://biotechstocks.com/22nd-century-group-inc-nysemktxxii-leads-the-market-by-producing-zero-thc-industrial-hemp-at-anandia-labs/20%Monthly2017-03-28 10:46
https://biotechstocks.com/northwest-biotherapeutics-inc-otcmktsnwbo-brings-to-a-close-its-registered-direct-offering-of-7-5-million-with-institutional-investors/20%Monthly2017-03-28 10:45
https://biotechstocks.com/peregrine-pharmaceuticals-nasdaqpphms-subsidiary-avid-bioservices-excited-after-being-graced-with-the-mutliple-2017-cmo-leadership-awards/20%Monthly2017-03-28 06:42
https://biotechstocks.com/insys-therapeutics-inc-nasdaqinsy-excited-after-getting-the-final-dea-rule/20%Monthly2017-03-28 06:38
https://biotechstocks.com/alxn-form-8-k-8/20%Monthly2017-03-27 12:43
https://biotechstocks.com/adxs-provides-phase-1-data-of-higher-dose-axalimogene-filolisbac/20%Monthly2017-03-27 12:41
https://biotechstocks.com/catalyst-pharmaceuticals-inc-nasdaqcprx-focused-on-u-s-approval-for-firdapse/20%Monthly2017-03-27 05:18
https://biotechstocks.com/alexion-pharmaceuticals-inc-nasdaqalxn-files-for-soliris-label-expansion-in-japan/20%Monthly2017-03-27 05:14
https://biotechstocks.com/amgen-inc-nasdaqamgns-amgevita-biosimilar-adalimumab-gets-european-commissions-nod-for-treatment-of-certain-inflammatory-diseases/20%Monthly2017-03-27 05:12
https://biotechstocks.com/shire-plc-adr-nasdaqshpg-rare-disease-drug-gets-fast-track-designation/20%Monthly2017-03-27 05:35
https://biotechstocks.com/mylan-n-v-nasdaqmyl-stock-dips-on-recall-of-81000-epipens-outside-u-s/20%Monthly2017-03-27 05:07
https://biotechstocks.com/scientists-may-have-discovered-new-avenue-of-treating-multiple-sclerosis-patients/20%Monthly2017-03-24 19:37
https://biotechstocks.com/aveo-pharmaceuticals-inc-nasdaqaveo-announces-first-patient-dosed-in-phase-12-tinivo-trial-of-tivozanib-and-opdivo-nivolumab-in-advanced-rcc/20%Monthly2017-03-24 10:34
https://biotechstocks.com/moleculin-biotech-inc-nasdaqmbrx-leukemia-drug-gets-orphan-status/20%Monthly2017-03-24 10:33
https://biotechstocks.com/biogen-inc-nasdaqbiib-despite-challnges-may-be-headced-to-the-right-directionin-terms-ofr-business-success/20%Monthly2017-03-24 09:12
https://biotechstocks.com/opko-health-inc-nasdaqopk-succeeds-in-achieving-the-orphan-status-for-genetic-disorder-drug/20%Monthly2017-03-24 09:10
https://biotechstocks.com/alexion-pharmaceuticals-inc-nasdaqalxns-drug-application-may-be-the-new-hope-for-patients-with-refractory-generalized-myasthenia-gravis/20%Monthly2017-03-24 09:08
https://biotechstocks.com/biotech-stock-news-molecular-templates-and-threshold-pharmaceuticals-inc-nasdaqthldto-merge/20%Monthly2017-03-23 15:06
https://biotechstocks.com/amgen-inc-nasdaqamgn-to-invest-in-tampa-bay-as-other-top-biotech-stocks-flock-to-the-area/20%Monthly2017-03-23 15:05
https://biotechstocks.com/pphm-receives-multiple-2017-cmo-leadership-awards/20%Monthly2017-03-23 12:31
https://biotechstocks.com/adxs-ema-certification-paves-the-way-for-the-maa-submission/20%Monthly2017-03-23 12:28
https://biotechstocks.com/an-acute-heart-failure-drug-by-one-of-the-best-biotech-stocks-novartis-ag-adr-nysenvs-flops/20%Monthly2017-03-23 12:06
https://biotechstocks.com/acquisition-of-vallee-s-a-completed-by-one-of-the-best-biotech-picks-merck-co-inc-nysemrk-animal-health/20%Monthly2017-03-23 12:05
https://biotechstocks.com/new-drug-application-for-binimetinib-withdrawn-by-one-of-the-top-biotech-stocks-array-biopharma-inc-nasdaqarry/20%Monthly2017-03-23 12:03
https://biotechstocks.com/advanced-treatment-for-depression-and-anxiety/20%Monthly2017-03-22 19:58
https://biotechstocks.com/scientists-may-have-discovered-a-way-to-predict-heart-attacks-before-they-happens/20%Monthly2017-03-21 19:31
https://biotechstocks.com/iddr-meet-hipaa-security-compliance-requirements/20%Monthly2017-03-21 12:42
https://biotechstocks.com/treatment-for-specific-types-of-breast-cancer-may-help-more-patients/20%Monthly2017-03-20 20:05
https://biotechstocks.com/blue-appoints-new-senior-manufacturing-and-corporate-development-executives/20%Monthly2017-03-20 12:51
https://biotechstocks.com/amgn-repath-study-outcome-results/20%Monthly2017-03-17 14:02
https://biotechstocks.com/cur-to-present-at-oppenheimer-healthcare-conference/20%Monthly2017-03-17 13:56
https://biotechstocks.com/cytx-to-webcast-q4-results-march-23rd/20%Monthly2017-03-17 13:54
https://biotechstocks.com/new-study-may-reverse-type-2-diabetes/20%Monthly2017-03-17 13:49
https://biotechstocks.com/eye-movement-desensitization-and-reprocessing-therapy/20%Monthly2017-03-16 19:41
https://biotechstocks.com/kite-announces-appointment-of-renowned-cancer-researcher-owen-n-witte-m-d/20%Monthly2017-03-16 13:12
https://biotechstocks.com/scientists-discovery-could-be-a-breakthrough-for-neurological-conditions/20%Monthly2017-03-15 19:40
https://biotechstocks.com/is-acupuncture-a-reliable-treatment-for-cancer/20%Monthly2017-03-14 19:55
https://biotechstocks.com/tg-therapeutics-inc-nasdaqtgtx-makes-its-announcement-in-relation-to-the-new-pricing-in-its-common-stock-public-offering/20%Monthly2017-03-14 10:40
https://biotechstocks.com/navidea-biopharmaceuticals-inc-nysemktnavb-strikes-deal-with-cardinal-health-inc-nysecah-as-crg-resolves-to-drop-liens/20%Monthly2017-03-14 09:16
https://biotechstocks.com/heat-biologics-inc-nasdaqhtbx-commands-a-great-controlling-stake-at-avexis-inc-nasdaqavxs/20%Monthly2017-03-14 09:16
https://biotechstocks.com/opko-health-inc-nasdaqopk-shines-some-light-on-the-genetic-neurological-disorder/20%Monthly2017-03-14 09:17
https://biotechstocks.com/cel-sci-corporation-nysemktcvm-gives-new-updates-regarding-the-phase-3-head-and-neck-cancer-study/20%Monthly2017-03-14 09:17
https://biotechstocks.com/the-future-of-biotech-industry/20%Monthly2017-03-13 19:39
https://biotechstocks.com/prtx-strengthens-global-intellectual-property-portfolio/20%Monthly2017-03-13 12:57
https://biotechstocks.com/adxs-present-at-the-2017-barclays-global-healthcare-conference/20%Monthly2017-03-13 12:55
https://biotechstocks.com/galena-biopharma-inc-nasdaqgale-in-need-of-canaccord-genuity-groups-advisory/20%Monthly2017-03-13 10:34
https://biotechstocks.com/glaxosmithkline-plc-adr-nysegsk-performs-quite-well-in-a-study-as-hope-surges-about-in-becoming-the-long-awited-solution/20%Monthly2017-03-13 10:34
https://biotechstocks.com/impressive-phase-iii-results-provides-incentive-to-ionis-pharmaceuticals-inc-nasdaqions/20%Monthly2017-03-13 10:34
https://biotechstocks.com/fda-approves-auryxia-tablets-keryx-biopharmaceuticals-nasdaqkerx-announces/20%Monthly2017-03-13 10:34
https://biotechstocks.com/ocera-therapeutics-inc-nasdaqocrx-yet-again-announces-encouraging-results-from-its-phase-2b-stop-he-study/20%Monthly2017-03-13 10:33
https://biotechstocks.com/stem-cell-treatment-may-be-effective-for-people-with-cerebral-palsy/20%Monthly2017-03-10 20:42
https://biotechstocks.com/new-cimzia-certolizumab-pegol-data-presented-at-american-academy-of-dermatology-2017-annual-meeting/20%Monthly2017-03-10 06:20
https://biotechstocks.com/intercept-pharmaceuticals-inc-nasdaqicpt-granted-nice-approval-for-ocaliva-for-use-in-england-wales-and-northern-ireland/20%Monthly2017-03-10 06:20
https://biotechstocks.com/fda-accepts-new-drug-application-and-grants-priority-review-for-enasidenib-in-relapsed-or-refractory-aml-with-an-idh2-mutation/20%Monthly2017-03-10 06:20
https://biotechstocks.com/bluebird-bio-inc-nasdaqblue-announces-publication-of-case-study-on-first-patient-with-severe-sickle-cell-disease-treated-with-gene-therapy/20%Monthly2017-03-10 06:19
https://biotechstocks.com/opko-health-inc-nasdaqopk-subsidiary-launches-prenatal-testing-tool/20%Monthly2017-03-10 06:19
https://biotechstocks.com/new-findings-may-better-help-diagnose-and-treat-people-with-crohns-disease/20%Monthly2017-03-09 20:37
https://biotechstocks.com/regn-8-k/20%Monthly2017-03-09 14:12
https://biotechstocks.com/lbio-form-10-k-2/20%Monthly2017-03-09 14:06
https://biotechstocks.com/dr-akhtar-ashfaq-appointed-by-opko-health-inc-nasdaqopk-as-renal-division-senior-vice-president-clinical-research-and-development/20%Monthly2017-03-09 11:42
https://biotechstocks.com/kite-pharma-inc-nasdaqkite-names-richard-l-wang-as-chief-executive-officer-of-fosun-kite-biotechnology-co-ltd/20%Monthly2017-03-09 11:23
https://biotechstocks.com/sanofi-sa-adr-nysesny-regeneron-pharmaceuticals-inc-nasdaqregn-say-latest-dupixent-eczema-drug-tests-positive/20%Monthly2017-03-09 11:10
https://biotechstocks.com/the-managing-director-for-alexion-pharmaceuticals-inc-nasdaqalxn-leonard-bell-resigns/20%Monthly2017-03-09 07:50
https://biotechstocks.com/bioverativ-inc-nasdaqbivv-one-of-the-best-biotech-stocks-appoints-anna-protopapas-as-a-board-member-in-a-bid-to-revamp-its-operations/20%Monthly2017-03-09 07:44
https://biotechstocks.com/new-possible-cure-for-sickle-cell-anemia/20%Monthly2017-03-08 20:58
https://biotechstocks.com/kite-announces-closing-of-public-offering-of-common-stock/20%Monthly2017-03-08 13:54
https://biotechstocks.com/bronstein-gewirtz-grossman-llc-notifies-investors-of-class-action-against-galena-biopharma-inc-nasdaqgale-and-lead-plaintiff-deadline/20%Monthly2017-03-08 05:29
https://biotechstocks.com/amgen-inc-nasdaqamgn-leukemia-drug-reports-better-survival/20%Monthly2017-03-08 05:26
https://biotechstocks.com/puma-biotechnology-inc-nasdaqpbyi-plunges-on-breast-cancer-drug-update/20%Monthly2017-03-08 05:21
https://biotechstocks.com/bioscrip-inc-nasdaqbios-raises-approximately-5-million-in-private-placement-of-common-stock/20%Monthly2017-03-08 05:17
https://biotechstocks.com/viewray-inc-nasdaqvrays-mridian-linac-gets-the-fda-510k-nod-viewray-inc-nasdaqvray/20%Monthly2017-03-08 05:03
https://biotechstocks.com/possible-new-treatment-for-high-blood-pressure-has-been-discovered/20%Monthly2017-03-07 20:40
https://biotechstocks.com/tech-signs-exclusive-license-agreement-with-multiclonal-therapeutics/20%Monthly2017-03-07 14:00
https://biotechstocks.com/amgn-recommended-for-metastatic-colorectal-cancer/20%Monthly2017-03-07 13:57
https://biotechstocks.com/regn-to-present-new-phase-3-praluent-alirocumab/20%Monthly2017-03-07 13:52
https://biotechstocks.com/adxs-appoints-al-blunt-m-d-as-its-vice-president-of-medical/20%Monthly2017-03-07 13:48
https://biotechstocks.com/adhd-to-participate-in-upcoming-healthcare-conferences/20%Monthly2017-03-07 13:44
https://biotechstocks.com/amgen-inc-nasdaqamgn-to-the-rescue-of-cancer-and-cancer-related-patients/20%Monthly2017-03-07 10:01
https://biotechstocks.com/oncogenex-pharmaceuticals-inc-nasdaqogxi-and-earth-life-sciences-inc-otcmktsclts-collaborate-to-spark-cystine-development/20%Monthly2017-03-07 05:36
https://biotechstocks.com/akorn-inc-nasdaqakrx-to-proceed-with-ephedrine-sulfate-injection-usp-after-receiving-approval-from-fda/20%Monthly2017-03-07 05:32
https://biotechstocks.com/celgene-corporation-nasdaqcelg-announces-oral-otezla-demonstrated-significant-improvement-vs-placebo-in-trial-of-patients-with-moderate-plaque-psoriasis/20%Monthly2017-03-07 05:13
https://biotechstocks.com/mplx-lp-nysemplx-subsidiary-closes-purchase-of-ozark-pipeline/20%Monthly2017-03-07 05:10
https://biotechstocks.com/new-treatment-for-joint-pain-could-be-through-stem-cell-therapy/20%Monthly2017-03-06 20:40
https://biotechstocks.com/pphm-to-report-financial-results-for-third-quarter-of-fiscal-year-2017/20%Monthly2017-03-06 13:53
https://biotechstocks.com/iddr-has-been-selected-by-european-based-software-services-company/20%Monthly2017-03-06 13:49
https://biotechstocks.com/aldr-announces-presentations-at-69th-annual-american-academy-of-neurology-meeting/20%Monthly2017-03-06 13:46
https://biotechstocks.com/ampio-pharmaceuticals-inc-nysemktampe-seeks-out-approval-for-ampion/20%Monthly2017-03-06 10:17
https://biotechstocks.com/a-new-dawn-for-cancer-patients-as-exact-sciences-corporation-nasdaqexas-and-mayo-look-forward-to-blood-based-lung-cancer-test/20%Monthly2017-03-06 10:18
https://biotechstocks.com/deaths-force-fda-to-suspend-the-drug-trial-by-juno-therapeutics-inc-nasdaqjuno/20%Monthly2017-03-06 10:07
https://biotechstocks.com/kite-pharma-inc-nasdaqkite-a-biotech-stocks-announces-pricing-of-public-offering-of-common-stock/20%Monthly2017-03-06 06:57
https://biotechstocks.com/biopharmx-corp-nysemktbpmx-presents-poster-at-american-academy-of-dermatology-annual-meeting-suggesting-bpx-01-safely-efficiently-delivers-acne-fighting-minocycline-to-pilosebaceous-units/20%Monthly2017-03-06 06:51
https://biotechstocks.com/targa-resources-corp-nysetrgp-biotech-stocks-company-completes-permian-acquisition/20%Monthly2017-03-06 06:52
https://biotechstocks.com/amgen-inc-nasdaqamgn-make-two-important-presentations-at-the-international-myeloma-workshop/20%Monthly2017-03-03 05:07
https://biotechstocks.com/cerecor-inc-nasdaqcerc-makes-the-review-of-strategic-alternatives-with-the-help-of-sun-trust-humphrey/20%Monthly2017-03-03 05:02
https://biotechstocks.com/celgene-corporation-nasdaqcelg-given-the-go-ahead-with-its-drug-application-by-fda/20%Monthly2017-03-03 04:57
https://biotechstocks.com/oncogenex-pharmaceuticals-inc-nasdaqogxi-participates-in-the-push-for-development-of-cystisine-for-smoking-cessation/20%Monthly2017-03-03 04:52
https://biotechstocks.com/accusations-against-mylan-n-v-nasdaqmyl-and-teva-pharmaceutical-industries-ltd-adr-nyseteva-two-of-the-top-biotech-stocks-in-the-market/20%Monthly2017-03-03 03:55
https://biotechstocks.com/biotech-spotlight-on-inmed-pharmaceuticals/20%Monthly2017-03-02 17:49
https://biotechstocks.com/kite-demonstrate-positive-results-in-b-cell-non-hodgkin-lymphoma/20%Monthly2017-03-02 13:48
https://biotechstocks.com/opko-health-inc-nasdaqopk-set-to-participate-in-illumina-inc-nasdaqilmns-ihope-program-on-international-rare-disease-day/20%Monthly2017-03-02 10:24
https://biotechstocks.com/4057/20%Monthly2017-03-02 04:34
https://biotechstocks.com/alexion-pharmaceuticals-inc-nasdaqalxn-banks-hope-in-its-metabolic-disease-drugs/20%Monthly2017-03-02 04:25
https://biotechstocks.com/ocera-therapeutics-inc-nasdaqocrx-expected-to-make-a-presentation-at-the-cowen-and-company-37th-annual-conference/20%Monthly2017-03-02 04:21
https://biotechstocks.com/incyte-corporation-nasdaqincy-raises-awareness-on-myeloproliferative-neoplasms-on-the-rare-disease-day-2017/20%Monthly2017-03-02 04:18
https://biotechstocks.com/possible-new-solution-for-the-hearing-impaired/20%Monthly2017-03-01 20:43
https://biotechstocks.com/tech-setting-a-new-standard/20%Monthly2017-03-01 13:37
https://biotechstocks.com/clinical-immuno-oncology-symposium-receives-two-immunotherapy-related-posters-from-celsion-corporation-nasdaqclsn/20%Monthly2017-03-01 07:10
https://biotechstocks.com/la-jolla-pharmaceutical-company-nasdaqljpc-may-be-the-hope-for-low-blood-pressure-patients/20%Monthly2017-03-01 07:08
https://biotechstocks.com/cempra-inc-nasdaqcemp-delighted-by-consistent-and-positive-phase-iii-results-for-skin-structure-treatments/20%Monthly2017-03-01 06:56
https://biotechstocks.com/biogen-inc-nasdaqbiib-alums-give-waltham-biotech-a-major-boost/20%Monthly2017-03-01 06:46
https://biotechstocks.com/amedica-corporation-nasdaqamda-winds-up-on-the-independent-femoral-head-wear-testing/20%Monthly2017-03-01 06:40